Cardiome Pharma Corporation EBITDA Margin 2016-2019 | CORV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cardiome Pharma Corporation (CORV) over the last 10 years. The current EBITDA margin for Cardiome Pharma Corporation as of September 30, 2019 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2019-09-30 | $0.03B | $-0.02B | -70.00% |
| 2019-03-31 | $0.03B | $-0.02B | -72.41% |
| 2018-12-31 | $0.03B | $-0.02B | -75.86% |
| 2018-09-30 | $0.03B | $-0.02B | -88.89% |
| 2018-06-30 | $0.03B | $-0.02B | -92.31% |
| 2018-03-31 | $0.03B | $-0.02B | -84.62% |
| 2017-12-31 | $0.02B | $-0.02B | -83.33% |
| 2017-09-30 | $0.02B | $-0.02B | -79.17% |
| 2017-06-30 | $0.02B | $-0.02B | -78.26% |
| 2017-03-31 | $0.02B | $-0.02B | -69.57% |
| 2016-12-31 | $0.03B | $-0.01B | -48.00% |
| 2016-09-30 | $0.02B | $-0.01B | -60.87% |
| 2016-06-30 | $0.02B | $-0.02B | -65.22% |
| 2016-03-31 | $0.02B | $-0.02B | -78.26% |
| 2015-12-31 | $0.02B | $-0.02B | -90.48% |
